Corcept Therapeutics, Inc. (CORT)
66.10
+5.74
(+9.51%)
USD |
NASDAQ |
May 27, 14:56
Corcept Therapeutics Free Cash Flow : 119.79M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 14.12B |
| Supernus Pharmaceuticals, Inc. | 82.24M |
| Assertio Holdings, Inc. | -7.081M |
| Nektar Therapeutics | -203.94M |
| Pfizer Inc. | 9.484B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.77M |
| Cash from Investing (Quarterly) | 4.542M |
| Cash from Financing (Quarterly) | 0.76M |
| Free Cash Flow Per Share (Quarterly) | -0.1625 |
| Free Cash Flow to Equity (Quarterly) | -20.50M |
| Free Cash Flow to Firm (Quarterly) | -16.97M |
| Free Cash Flow Yield | 1.56% |